Ann Surg 2000 Sep;232(3):381-91
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Download full-text PDF
Ann Surg Oncol 2005 Aug 20;12(8):616-28. Epub 2005 Jun 20.
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, Texas, 77030-4009, USA.
Background: Radiofrequency ablation (RFA) offers an alternative treatment in some unresectable hepatocellular carcinoma (HCC) patients with disease confined to the liver. We prospectively evaluated survival rates in patients with early-stage, unresectable HCC treated with RFA.
Methods: All patients with HCC treated with RFA between September 1, 1997, and July 31, 2002, were prospectively evaluated. Read More
Zhonghua Wai Ke Za Zhi 2005 Aug;43(15):980-4
Ultrasound Department of Clinical Oncology School, Peking University, Beijing 100036, China.
Objective: To assess the efficiency and safety of radiofrequency ablation (RFA) of recurrent hepatocellular carcinoma (RHCC) after hepatectomy and to investigate efficacy of RFA for patients with early and late phase recurrence, separately, setting 1 year as the cut-off between the early and late phases.
Methods: A total of 42 patients with 77 RHCC and a history of hepatic resection for hepatocellular carcinoma (HCC) underwent ultrasound-guided percutaneous radiofrequency ablation in our department and entered this study (RHCC group). The average diameter of RHCC was (3. Read More
Eur J Ultrasound 1999 May;9(2):145-53
Divisione di Gastroenterologia, Ospedale 'Cardinale Ascalesi', ASL Napoli 1, Via Egiziaca a Forcella 44, Napoli, Italy.
Objective: Radiofrequency hyperthermia using the newly-developed 'cooled-tip' needle has recently been proposed as a therapeutic modality for hepatocellular carcinoma (HCC). Herein we report our preliminary results on feasibility and effectiveness of the thermal ablation of mono- or pauci-focal hepatocellular carcinoma with the cooled-tip needle.
Materials And Methods: We treated 15 cirrhotic patients (mean age 68. Read More
Am Surg 2001 Dec;67(12):1181-4
Department of Surgery, University of California, Irvine Medical Center, Orange 92868, USA.
The optimal treatment for hepatocellular carcinoma (HCC) is surgical resection. However, only a small percentage of patients are operative candidates. CT-guided percutaneous radiofrequency ablation (RFA) has been shown to be efficacious in treatment of unresectable HCC. Read More